JP2016516028A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516028A5
JP2016516028A5 JP2016500471A JP2016500471A JP2016516028A5 JP 2016516028 A5 JP2016516028 A5 JP 2016516028A5 JP 2016500471 A JP2016500471 A JP 2016500471A JP 2016500471 A JP2016500471 A JP 2016500471A JP 2016516028 A5 JP2016516028 A5 JP 2016516028A5
Authority
JP
Japan
Prior art keywords
methyl
optionally substituted
inden
hydrogen
hydroxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500471A
Other languages
English (en)
Japanese (ja)
Other versions
JP6407950B2 (ja
JP2016516028A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/019125 external-priority patent/WO2014143561A1/en
Publication of JP2016516028A publication Critical patent/JP2016516028A/ja
Publication of JP2016516028A5 publication Critical patent/JP2016516028A5/ja
Application granted granted Critical
Publication of JP6407950B2 publication Critical patent/JP6407950B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500471A 2013-03-14 2014-02-27 Ship1モジュレーターおよびそれに関連する組成物および方法 Expired - Fee Related JP6407950B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785860P 2013-03-14 2013-03-14
US61/785,860 2013-03-14
PCT/US2014/019125 WO2014143561A1 (en) 2013-03-14 2014-02-27 Ship1 modulators and methods related thereto

Publications (3)

Publication Number Publication Date
JP2016516028A JP2016516028A (ja) 2016-06-02
JP2016516028A5 true JP2016516028A5 (enExample) 2017-02-09
JP6407950B2 JP6407950B2 (ja) 2018-10-17

Family

ID=50288306

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016500471A Expired - Fee Related JP6407950B2 (ja) 2013-03-14 2014-02-27 Ship1モジュレーターおよびそれに関連する組成物および方法

Country Status (13)

Country Link
US (2) US10100056B2 (enExample)
EP (1) EP2970100A1 (enExample)
JP (1) JP6407950B2 (enExample)
KR (1) KR20150130426A (enExample)
CN (1) CN105209429B (enExample)
AU (1) AU2014228574B2 (enExample)
BR (1) BR112015022577A2 (enExample)
CA (1) CA2902764A1 (enExample)
HK (1) HK1220173A1 (enExample)
IL (1) IL241168A0 (enExample)
MX (1) MX2015011280A (enExample)
RU (1) RU2015143675A (enExample)
WO (1) WO2014143561A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1216886A1 (zh) 2013-01-09 2016-12-09 Aquinox Pharmaceuticals (Canada) Inc. Ship1调节剂和与其相关的方法
BR112015022577A2 (pt) 2013-03-14 2017-07-18 Aquinox Pharmaceuticals Canada Inc moduladores ship1 e métodos relacionados a esse
EP2970122B1 (en) 2013-03-14 2019-05-08 Aquinox Pharmaceuticals (Canada) Inc. Ship1 modulators
US9944590B2 (en) 2015-06-26 2018-04-17 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative
US20190047939A1 (en) * 2016-03-02 2019-02-14 Patheon Austria Gmbh & Co Kg Process and intermediates for the production of 17(20)-ene b-seco steroids
WO2018126040A1 (en) 2016-12-28 2018-07-05 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of (1s,3s,4r)-4-((3as,4r,5s,7as)-4- (aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3- (hydroxymethyl)-4-methylcyclohexanol
ES2960542T3 (es) 2018-04-06 2024-03-05 Taro Pharmaceuticals Inc Derivados de hexadecahidro-1H-ciclopenta[a]fenantreno útiles en el tratamiento del dolor y la inflamación
CN112543753A (zh) * 2018-04-06 2021-03-23 塔罗制药公司 可用于治疗疼痛和炎症的茚衍生物
AU2019247496A1 (en) * 2018-04-06 2020-10-22 Taro Pharmaceuticals Inc. Indene derivatives useful in treating pain and inflammation
CN111056962B (zh) * 2019-11-28 2022-08-05 重庆爱旭龙科技有限公司 一种诺司普托及其醋酸盐的制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1084718B (de) 1958-07-08 1960-07-07 Bayer Ag Verfahren zur Herstellung von Secosteroiden
SE345995B (enExample) 1969-01-31 1972-06-19 Bristol Myers Co
US3682983A (en) 1969-11-12 1972-08-08 Klaus Prezewowsky Preparation of {66 {11 {11 -17 ethinyl steroids
US3869467A (en) 1972-06-05 1975-03-04 Hoffmann La Roche 17-{62 -Hydroxy-17-{60 -methyl-5-{60 -androstano{9 3,2-c{9 or{8 2,3-d{9 isoxazoles
US3962275A (en) 1972-06-05 1976-06-08 Hoffmann-La Roche Inc. 7-oxa steroids
JPH01290624A (ja) 1988-05-16 1989-11-22 Shiono Chem Kk 5,6―セコ―ステロール誘導体血清脂質低下剤
EP0641356B1 (en) 1991-12-20 1998-04-22 Glaxo Wellcome Inc. Inhibitors of 5-alpha-testosterone reductase
JPH05221924A (ja) 1992-02-17 1993-08-31 Shiono Chem Kk セコステロール化合物
JPH05221901A (ja) 1992-02-17 1993-08-31 Shiono Chem Kk セコステロール誘導体
US5464866A (en) 1992-08-17 1995-11-07 Alcon Laboratories, Inc. Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
AP459A (en) 1992-12-18 1996-02-14 Glaxo Wellcome Inc Substituted 6-azaandrostenones.
ATE191712T1 (de) 1993-07-09 2000-04-15 Theramex Neue strukturelle vitamin d derivate
US5541322A (en) 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US6046185A (en) 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
WO2000063323A1 (en) 1999-04-16 2000-10-26 Nippon Mitsubishi Oil Corporation Fluids for traction drive
RU2291873C2 (ru) 2000-04-28 2007-01-20 Инфлазим Фармасьютикалз Лимитед 3-амино-6,7-дикислородсодержащие стероиды, фармацевтическая композиция, способы лечения
US6696580B2 (en) 2001-05-22 2004-02-24 Inflazyme Pharmaceuticals Ltd. Process for the production of 6,7-diols of steroidal compounds
WO2003033517A1 (en) 2001-10-17 2003-04-24 The University Of British Columbia Ship 1 modulators
DE60327936D1 (de) 2002-10-17 2009-07-23 Univ British Columbia Modulatoren von ship-1
CA2521883C (en) 2003-04-15 2013-09-17 Inflazyme Pharmaceuticals Ltd. Indene derivatives as pharmaceutical agents
CA2656339A1 (en) 2006-06-21 2007-12-27 The University Of British Columbia Ship 1 modulator prodrugs
WO2011069118A1 (en) 2009-12-04 2011-06-09 Aquinox Pharmaceuticals Inc. Ship1 modulators and methods related thereto
EP2970122B1 (en) 2013-03-14 2019-05-08 Aquinox Pharmaceuticals (Canada) Inc. Ship1 modulators
BR112015022577A2 (pt) 2013-03-14 2017-07-18 Aquinox Pharmaceuticals Canada Inc moduladores ship1 e métodos relacionados a esse
US9944590B2 (en) 2015-06-26 2018-04-17 Aquinox Pharmaceuticals (Canada) Inc. Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
WO2017127753A1 (en) 2016-01-20 2017-07-27 Aquinox Pharmaceuticals (Canada) Inc. Synthesis of a substituted indene derivative

Similar Documents

Publication Publication Date Title
RU2015143675A (ru) Ship1 модуляторы и относящиеся к ним способы
RU2457209C2 (ru) Производные пурина, предназначенные для применения в качестве агонистов аденозинового рецептора а2а
JP2014508128A5 (enExample)
IL264982B (en) Hetero(aryl)cyclopropylamine compounds as lsd1 inhibitors
JP2021515033A5 (enExample)
RU2017116197A (ru) 2-амино-3,5-дифтор-3,6-диметил-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 для лечения болезни альцгеймера
JP2021529812A5 (enExample)
JP2010534654A5 (enExample)
RU2000126841A (ru) Производные амида и антагонисты ноцицептина
JP2012515166A5 (enExample)
JP2017533968A5 (enExample)
JP2017511794A5 (enExample)
RU2006145205A (ru) Терапевтические соединения: пиридин в качестве каркаса
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1
JP2015509110A5 (enExample)
JP2012517470A5 (enExample)
JP2016523923A5 (enExample)
RU2015144653A (ru) Противовирусные соединения и их применения
JP2005511508A5 (enExample)
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
JP2017530199A5 (enExample)
JP2015514679A5 (enExample)
JP2008500336A5 (enExample)
JP2014518853A5 (enExample)
JP2010540462A5 (enExample)